Laboratorios LETI has always viewed health care as a highly profitable investment and not as an expense to be minimised. Health should not be based principally on the treatment of an illness. Looking after your body whether during health or sickness, including vaccines and an early diagnosis contribute significantly to improving the quality of life and well-being, as well as reducing the impact and social cost of illness. Consistent with this philosophy, Laboratorios LETI offers not only treatments but also a wide range of products for disease prevention, early diagnosis and specialised body care.
The foundation of our competitive edge lies in our research and specialisation. We are confident that our current R&D programmes, which focus on allergy, immunology, skin, hygiene and specific female requirements, will entitle Laboratorios LETI to continue setting the lead in the market through differentiation and innovation. The fruits of our research, Depigoid®, TOL®, Letitest, LETI AT4, Letibalm, Urealeti and LETIFEM lines, are already the main source of revenue and growth of Laboratorios LETI.
International expansion constitutes an essential element of our strategy. A requirement to enable a specialised company to expand is to enter international markets. This is made easier by having our own products developed from our research. Thus, to Laboratorios LETI, international expansion is both a need and an opportunity as well as being an important rewarding element for the organisation. Laboratorios LETI has subsidiaries in Germany and Portugal and 14% 28% of its sales originate from exports.
Laboratories LETI maintains a strategy of close and lasting cooperation with companies in the industry in order to enhance its international presence (Novartis, Laboratorios Bagó de Chile, Armstrong Laboratorios de Mexico and Farmacias Ahumada) and to expand its product range (Sebapharma). The same applies with universities and investigation centres for research and development projects both in Spain and abroad. And there are discussions underway to widen these alliances in various sectors and markets. The company has the capacity and vocation to complement organic growth through corporate operations. But the essential element for the current and future success of Laboratorios LETI is undoubtedly, its people: competent professionals committed to the mission of the company to be among the leaders in specialised segments of health care, on the basis of innovative and effective products, excellent service and creating value for the shareholders. Rigorous decision-making, innovation, teamwork and continuous training, resulting from applying the values of the company, is our best guarantee of progress.